Company
»
»
About Us
Our Core Values
Our History
Our Mission
Core Competency
Quality Management
Manufacturing Facilities
Research and Development
Corporate Social Responsibility
Therapeutic Areas
Investors
»
»
Board of Directors
Corporate Governance
Code of Conduct
Stock Info
Abridged Annual Report
Green Initiative
Public Notice
Products
»
»
API
»
»
EU
USA
Other Pharmerging Markets
Notice for C&E Program
Dosage Forms
»
»
EU
Rest of World
Product Query
Careers
»
»
Current Openings
Policies
»
»
»
BMW reports
»
»
Kalyani
BMW AR-2021 Kalyani
BMW Authorisation Kalyani
Baddi
BMW Authorization Baddi
BMW AR-2021 Baddi
CSR Policy
Vigil Mechanism Policy
Prevention of Sexual Harassment Policy
Appointment Nomination and Remuneration Policy
Contact
Search:
Investors
Investors
Board of Directors
Corporate Governance
Code of Conduct
Stock Info
Dividend History
Public Notice
Overall Expertise
Manufacturing Facilities
Research & Development
Public Notice
FKOL Notice Capital Reduction 09.07.2020
Fresenius Kabi Oncology Limited Postal Ballot Notice
Newspaper Notice BS (ENGLISH)
Newspaper Notice BS (HINDI))
Notice_Record Date & Book Closure_BS (ENGLISH & Hindia)_16.06.2020
Top
Print this page
Send link to a friend
From Email:
To Email :
© All Copyright Reserved | Fresenius Kabi Oncology Limited 2012
Data Protection
|
Imprint
|
Legal Disclaimer
|
Sitemap